|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.157 +0.002 (+1.290%) | 2026/06 - Interim HKD(K$) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (29,636) | (49,873) | 2,183 | (26,372) |
| Net Cash from / (used in) Investing Activities | -- | (9,381) | (4,656) | (70,947) | (17,246) |
| Net Cash from / (used in) Financing Activities | -- | 27,321 | 35,743 | (26,212) | 102,631 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (11,696) | (18,786) | (94,976) | 59,013 |
| Cash & Cash Equivalents at beginning of period | -- | 16,317 | 34,493 | 128,098 | 60,198 |
| Effect of Foreign Exchange Rate Changes | -- | 442 | 610 | 1,371 | 8,887 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 5,063 | 16,317 | 34,493 | 128,098 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 197,848 |
| %Change | 1659.744% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 0.050 |